Mob1 ͉ Mst1 knockout ͉ RAPL ͉ hippo ͉ Stk4 M st1 and Mst2 are closely related mammalian class II GC protein (ser/thr) kinases (1) whose overexpression induces apoptosis in many transformed cell lines through a combination of p53-and Jnk-dependent pathways (2-4). Regarding the physiological roles of these kinases, Kinashi and colleagues demonstrated that the ability of ␣CD3/␣CD28 and chemokines to promote the Rap1-GTP-dependent integrin clustering necessary for T cell adhesion and migration (5) is strongly dependent on Mst1 (6), which is proposed to be activated through the Rap1-GTP recruitment of a Nore1B (also called RAPL)/Mst1 complex to the immunological synapse (7). The Mst1 substrate(s) that mediate this response is (are) not known. Mst1 and Mst2 are found in constitutive complexes with members of the Rassf polypeptide family (8, 9), at least two of which, RASSF1A and Nore1A/RASSF5, are well established tumor suppressors (10). Nevertheless, direct evidence in support of a tumor suppressor function for Mst1 and/or Mst2 is not yet available.
Mob1 ͉ Mst1 knockout ͉ RAPL ͉ hippo ͉ Stk4 M st1 and Mst2 are closely related mammalian class II GC protein (ser/thr) kinases (1) whose overexpression induces apoptosis in many transformed cell lines through a combination of p53-and Jnk-dependent pathways (2) (3) (4) . Regarding the physiological roles of these kinases, Kinashi and colleagues demonstrated that the ability of ␣CD3/␣CD28 and chemokines to promote the Rap1-GTP-dependent integrin clustering necessary for T cell adhesion and migration (5) is strongly dependent on Mst1 (6) , which is proposed to be activated through the Rap1-GTP recruitment of a Nore1B (also called RAPL)/Mst1 complex to the immunological synapse (7) . The Mst1 substrate(s) that mediate this response is (are) not known. Mst1 and Mst2 are found in constitutive complexes with members of the Rassf polypeptide family (8, 9) , at least two of which, RASSF1A and Nore1A/RASSF5, are well established tumor suppressors (10) . Nevertheless, direct evidence in support of a tumor suppressor function for Mst1 and/or Mst2 is not yet available.
Mst1 and Mst2 resemble most closely the drosophila protein kinase hippo and human Mst2 can complement hippo deficiency (11) . Loss of hippo function results in massive overgrowth of the fly eye, due to an acceleration of cell proliferation together with a deficit in developmental apoptosis (11) (12) (13) (14) . The pathway downstream of hippo has been extensively described (15) (16) (17) . Hippo phosphorylates the protein kinase warts/LATS, which is facilitated by the binding of both kinases to the noncatalytic scaffold protein salvador/shar-pei; hippo also phosphorylates the noncatalytic protein MATS, which then binds to warts/LATS, promoting its autophosphorylation and activation. Activated warts, in turn, phosphorylates and negatively regulates the transcriptional coactivator yorkie. Loss of hippo, warts/LATS, Salvador, or MATS each results in overgrowth of a similar nature, whereas yorkie loss-of-function reduces growth and is epistatic to the other components. Studies in mammalian systems indicate that this pathway is largely conserved; LATS1 (18) and MOBKL1A/B (19) , the mammalian orthologs of warts/ LATS and MATS, are Mst1/2 substrates and negative regulators of cell proliferation (19, 20) . Moreover, mice lacking LATS1 develop soft tissue sarcomas and ovarian tumors (21) . Reciprocally, YAP, a mammalian homolog of yorkie, is phosphorylated and negatively regulated by LATS1 (22) (23) (24) . YAP is amplified in a wide variety of murine and human tumors (25) ; overexpression of YAP transforms mammary epithelial cells in vitro (25) and produces hyperplasia and cancer in mouse liver (22, 26) . As regards other outputs, Mst1 activated by oxidant stress phosphorylates the Foxo1/3a polypeptides in their forkhead domain, disrupting 14-3-3 binding and inhibiting the ability of Akt to promote Foxo1/3a nuclear exit (27) .
To define more fully the physiologic roles of Mst1, we generated mice lacking Mst1 polypeptide expression.
Results

Mst1-Deficient Lymphoid Cells Exhibit Much Lower Nore1B
Polypeptide but Unaltered Mst2. Mice lacking Mst1 polypeptide expression were generated from an ES cell line bearing a gene trap inserted between the first and second exons (see supporting information (SI) Fig. S1 ). Mst1-deficient mice survive development, are fertile, and appear unremarkable. Mst1 is expressed at greatest abundance in lymphoid organs (Fig. 1A) ; lymphocytes from the Mst1 trap/trap mice (henceforth called Mst1 Ϫ/Ϫ ) lack Mst1 polypeptide but show unaltered levels of Mst2 (Fig. 1B Left) . Mst1 can be coprecipitated with rassf family polypeptides (9); in lymphocytes, the Rassf5 isoform Nore1B/RAPL, a Ras-Rapbinding protein, is a major Mst1 partner (6) . Surprisingly, the level of the Nore1B/RAPL polypeptide is greatly diminished in the Mst1-null lymphocytes (Fig. 1B Left) despite unaltered Nore1B mRNA levels (Fig. 1B Right) , whereas the homologous protein Rassf1C is unaltered. The decrease in Nore1B polypeptide in the Mst1 Ϫ/Ϫ cells is probably due to the lack of Mst1 polypeptide per se, inasmuch as transient coexpression of Nore1B with either wild-type Mst1 or kinase-dead Mst1(K59R) in HEK293 cells results in higher steady-state levels of Nore1B polypeptide than when Nore1B is expressed alone (Fig. 1C ).
Mst1-Deficient Mice Exhibit Intact T Cell Development but Fewer Naïve Peripheral T Cells and a High Proportion of Effector/Memory T Cells in Liver and Lung. The thymus in the Mst1
Ϫ/Ϫ mice is normal in size and histologic appearance (Fig. S2 A) and the total number of thymocytes is comparable with Mst1 ϩ/ϩ littermates; the fraction of both CD4 ϩ and CD8 ϩ cells is slightly, but not significantly increased (Fig. S2 B and C) . In the blood the number of CD4 ϩ , CD8 ϩ and total T cells is greatly reduced (Fig.  2A) . The Mst1 Ϫ/Ϫ spleen shows a reduction in white pulp (Fig.  S3A ) and the numbers of CD4 ϩ , CD8 ϩ , and total T cells are also reduced (Fig. 2B) ; in addition the number of B220 ϩ cells is diminished (data not shown) and, as observed in mice lacking expression of Nore1B/RAPL (7), marginal zone B cells are essentially absent (Fig. S3 B and C) . In the Mst1 Ϫ/Ϫ spleen ( Fig.  2B and Fig. S4B ) and lymph nodes (Fig. S5 ) as well as in the circulation ( Fig. 2 A and Fig. S4A ), the fraction of CD4 ϩ and CD8 ϩ exhibiting the CD62Lhi/CD44lo naïve phenotype (28) is markedly reduced, whereas the fraction of CD4 ϩ and CD8 ϩ cells bearing the CD62Llo/CD44hi phenotype (a mixture of activated effector and memory cells) is reciprocally increased; the absolute numbers of CD62Llo/CD44hi cells in the circulation (Fig. 2 A) and spleens (Fig. 2B ) of the Mst1-null and wild-type mice are generally similar, although significantly higher number of CD4 ϩ CD62Llo/CD44hi cells are present in the spleens of Mst1-null mice. The abundance of regulatory T cells (Treg), as reflected by the numbers of CD4 ϩ Foxp3 ϩ cells (29) , is similar in the wild-type and Mst1 Ϫ/Ϫ spleens (Fig. S6) . We compared some nonlymphoid tissues of wild-type and Mst1-null mice for the abundance of T cells. Notably, the relative abundance of CD4 mRNA in Mst1-null lung and liver is 2-2.5-fold greater than in wild-type tissues (Fig. 2C Left) . A cytofluormetric analysis of CD4 ϩ cells in digests of lungs from wild-type or Mst1-null mice (Fig. 2C Right) demonstrates that the CD4 ϩ cells residing in the lung of the Mst1-null mice exhibit a far higher proportion of the CD62Llo/CD44hi effector/memory phenotype than the CD4 ϩ cells resident in the lung of wild-type mice. In summary, the secondary lymphoid organs of the Mst1-null mice contain fewer mature, naïve T cells but similar or slightly higher numbers of effector/memory cells; conversely, the lung, liver and heart of the Mst1-null mice contain higher numbers of CD4 ϩ cells that, in the lung, are predominantly effector/memory cells.
Mst1-Deficient Naïve T Cells Exhibit Much Stronger Proliferative
Responses to ␣CD3. We next examined some functional responses of purified peripheral T cells. The incorporation of 3 H-thymidine in response to both ␣-CD3 and to ␣-CD3/␣-CD28 in vitro in total T cells from Mst1-null spleens is two-to fivefold greater than in There is a significant reduction in the total numbers of CD4 ϩ and CD8 ϩ T cells in the Mst1-null spleens that is due largely to a reduction in the total numbers of naïve CD4 ϩ /CD62Lhi and CD8 ϩ /CD62Lhi subsets. There is a reciprocal increase in the percentage of effector/memory CD4 ϩ and CD8 ϩ cells (labeled CD44 ϩ ) but the total cell numbers in those subsets is comparable or slightly increased in the Mst1-null (n ϭ 6 pairs of Mst1-null and wild-type littermates). (C) The relative abundance of CD4 ϩ mRNA and CD4 ϩ T cell subsets in some nonlymphoid tissues. Left, Total RNA was isolated from the indicated tissues of wild-type and Mst1-null mice. The amount of CD4 mRNA relative to that of ␤-actin was measured by Q-PCR and the value for the Mst1-null (KO) was divided by the wild-type value. The abundance of CD4 mRNA in the lung, heart, and liver of Mst1-null mice is significantly higher than that in the corresponding wild-type tissue. Right, the CD4 ϩ cells present in digests of the lungs of wild-type and Mst1-null mice were analyzed for expression of CD62L and CD44 by cytofluorimetry. An equal number of cells from each digest was counted.
T cells from spleens of wild-type littermates (Fig. 3A) . This hyperproliferative response of Mst1-deficient total splenic T cells is also seen in cells stained with CFSE, which undergo some cell division in vitro even in the absence of any added stimulus (Fig. S7 ). Examining the CD4 ϩ subsets, it is evident that the up-regulated proliferative response is due entirely to a marked hyperproliferation of the Mst1-null CD62Lhi naïve cells (Fig.  3B) ; furthermore, their high incorporation of 3 H-thymidine in response to ␣-CD3 is only modestly augmented by the additional stimulation with ␣CD28. In contrast, the Mst1-null CD4 ϩ / CD62Llo cells show a proliferative response that is similar to that of the matched wild-type subset. Thus, the deficiency of Mst1 results in a dramatic up-regulation and disinhibition of the proliferative response of naïve T cells to engagement of the T cell receptor but little or no change in the response of the effector/ memory cohort.
The Mst1-null CD4 ϩ T cells also show enhanced production of the cytokines IL-2, IFN-␥, and IL-4 in response to ␣-CD3, both in the absence and presence of ␣-CD28 (Fig. S8) . In contrast to the hyperproliferative response, which is observed only in the Mst1-null naïve T cells, both the naïve and effector/ memory T cell cohorts from Mst1-null mice exhibit enhanced cytokine production. Elimination of Mst1 does not, however, alter the proclivity of naïve CD4 ϩ cells to differentiate toward a Th1 or Th2 phenotype in vitro in response to the appropriate stimulation (Fig. S9) .
In Normal Mice, Mst1 and Nore1B Polypeptide Levels Are Greatly Reduced in Effector/Memory Compared With Naïve T Cells. The marked disinhibition of the proliferative response engendered by Mst1 removal led us to inquire whether down-regulation of Mst1 expression is a normal part of the program for the transition of T cells from a naïve to an activated effector or memory phenotype. Strongly in support of this view, the abundance of the Mst1 polypeptide (Fig. 3C Left) and mRNA (Fig. 3C Center) in wild-type CD4 ϩ /CD62Llo effector/memory cells is reduced approximately 10-fold compared with that in the wild-type CD4 ϩ / CD62Lhi naïve cells, whereas the content of Mst2 polypeptide (Fig. 3C Left) is similar in these two subsets. Moreover, the abundance of the Nore1B polypeptide (Fig. 3C Left) in the CD4 ϩ /CD62Llo subset is reduced in parallel to Mst1 and to a similar extent. These data identify Mst1 as a likely determinant of the threshold for activation of naïve T cells (30) . Naïve cells lacking Mst1 gene expression entirely, as well as wild-type memory cells, which exhibit greatly reduced levels of Mst1 and Nore1B, both exhibit a much more robust proliferative response to TCR stimulation compared with wild-type naïve cells. The augmented cytokine responses of the Mst1-null effector/memory CD4 ϩ cohort (Fig. S8) , unaccompanied by an augmented proliferative response (Fig. 3B Right) implies that the low level of Mst1 that prevails in differentiated CD4 ϩ cells no longer exerts an antiproliferative effect but continues to restrain T cell cytokine production. activated in vivo even without exogenous immunization and lost thereafter through apoptosis (31) . We therefore measured the Annexin V surface reactivity of freshly isolated total T cells, an indicator of ongoing apoptosis. Regardless of the source, the prevalence of Annexin V reactivity is much higher in the freshly isolated Mst1-null T cells than the wild-type T cells (Fig. 3D) , consistent with an increased rate of T cell apoptosis in vivo. Overexpression of Mst1 per se is well known to promote apoptosis (8) , so that the higher rate of in vivo apoptosis in the Mst1-null T cells appeared paradoxical. We therefore examined the occurrence of apoptosis in vitro in response to ␣CD3 and ␣CD3ϩ␣CD28 (Fig. 3E) . In response to TCR stimulation in vitro, the Mst1-null naïve T cells do show less apoptosis compared with wild-type naïve cells; in contrast, the Mst1-null effector/memory cells continue to exhibit in vitro the higher rate of apoptosis seen in vivo, indicating that Mst1 does not exert an appreciable proapoptotic effect in this subset.
Elimination of Mst1 Inhibits ␣CD3-Induced LFA-1 Clustering. The low numbers of peripheral CD4/CD62L hi cells in the Mst1-null mice led us to examine the expression of various chemokine and adhesion receptors on these cells compared with wild type (Fig.  S10 ). The abundance of mRNA encoding KLF2, a transcription factor critical for maintenance of the chemokine receptor pattern of naïve T cells (32) , and the mRNAs encoding CCR7 and CXCR4, the dominant chemokine receptors in naïve T cells (33) , is similar in wild-type and Mst1-null CD4/CD62Lhi cells (Fig.  S10 Upper) . Although their absolute abundance is very low, modest up-regulation of CCR6 and CXCR3 mRNA is evident in the Mst1-null cells (Fig. S10 Lower) , perhaps reflecting some admixture of central memory cells (33) . These data indicate that the low numbers of peripheral CD4/CD62Lhi cells in the Mst1-null mice are not due to altered expression of their chemokine or adhesion receptors.
Elimination of Nore1B/RAPL (7) or depletion of Mst1 (6) is reported to interfere with inside-out signaling to T cell integrins. In confirmation, we find that elimination of Mst1 reduces the ability of TCR activation and chemokines to promote T cell adhesion to ICAM-1 whereas the response to PMA is unaffected (Fig. 4A Left) . In addition, the migration of Mst1-null T cells toward CCL21/SLC is also substantially reduced, although in comparing CD4 ϩ naïve cells from Mst1 and wild-type spleens, the magnitude of this reduction, although significant, is less (Fig.  4A Right) . The ability of ␣-CD3 or SLC to induce the clustering of LFA-1 is also diminished in the Mst1-null T cells (Fig. 4B) . Thus, as with the deletion of Nore1B/RAPL itself, the elimination of Mst1, which is accompanied by a marked decrease in Nore1B/RAPL, impairs LFA-1 clustering and adhesion.
T Cell Tyrosine Phosphorylation, Ca ؉؉ Mobilization, and MAPK Activation Are Unimpaired by Mst1 Deficiency. To gain insight into the molecular basis for the hyperproliferative response exhibited by Mst1 Ϫ/Ϫ naive cells, we examined several of the signal transduction pathways relevant to T cell growth control (34, 35) . The increase in tyrosine phosphorylation into total cellular polypeptides and specifically into CD3, ZAP70, Lck, and PLC␥ in response to ␣-CD3ϩ␣-CD28 is similar in splenic T cells from wild-type and Mst1-null mice (Fig. S11 A) . In addition, the increase in cytosolic (Ca 2ϩ ) in Mst1-null and wild-type CD4 ϩ / CD62Lhi naïve T cells in response to cross-linking ␣-CD3 is identical (Fig. S11B) . Examining more distal responses, the ability of ␣CD3 ϩ ␣CD28 to stimulate the phosphorylation of erk, p38, and Akt at sites necessary for the activation of these kinases, as well as the phosphorylation of IB is indistinguishable in total splenic T cells from Mst1-null and wild-type mice, whereas TCR activation of Jnk is more robust and sustained in the Mst1-null cells (Fig. S11C Left) . A similar pattern is observed in comparing the Mst1-null and wild-type CD4 ϩ /CD62Lhi naïve subsets, except that evidence for Jnk hyperactivation in the Mst1-null is lacking (Fig. S11C Right) .
Stimulation of the T Cell Receptor Activates Mst1 and Promotes
Phosphorylation of a Subset of Mst1-Dependent Substrates. Mst1 and Mst2 are 76% identical and share an identical activation loop sequence. Mst1/2 activation requires autophosphorylation of the activation loop, which can be monitored as a reflection of the activation state (9) . Mammalian Lats1 is directly phosphorylated at a carboxyl-terminal site by Mst2 (18) , which together with Lats1 activation loop autophosphorylation results in Lats1 activation. Lats1 in turn phosphorylates and inhibits YAP by promoting nuclear exit (22) (23) (24) . Mst1/2 phosphorylates the mammalian MATS orthologues, MOBKL1A and MOBKL1B (at Thr-12 and Thr-35), which enables MOBKL1A/B binding to Lats1 and promotes Lats1 autophosphorylation; MOBKL1A/B phosphorylation per se is sufficient to inhibit cell cycle progression in U2OS cells (19) . The FoxO1/3a polypeptides are also well documented Mst1 substrates (27) . Stimulation of splenic total T cells from wild-type mice with ␣CD3 ϩ ␣CD28 results in a rapid activation of Mst1/2 activation loop phosphorylation, which is completely lacking in the Mst1-null T cells (Fig. 5A Left) , indicating that Mst2 contributes very little to overall Mst1/2 activity in T cells. Concomitant with Mst1 activation, a brisk phosphorylation of MOBKL1A/B is evident in the wild-type T cells, and as with Mst1 autophosphorylation, this is completely absent in the Mst1-null T cells. Stimulation of wild-type T cells with ␣-CD3 ϩ ␣-CD28 produces a modest increase in Lats1/2 carboxyl-terminal phosphorylation and a somewhat slower increase in Lats1/2 activation loop phosphorylation. Elimination of Mst1 has little effect on the Lats1 carboxyl-terminal phosphorylation and no effect on Lats1/2 autophosphorylation. In response to ␣-CD3 ϩ ␣-CD28, a slight increase in YAP phosphorylation is evident, which is similar in the wild-type and Mst1-null T cells, whereas Foxo1/3a phosphorylation is unaltered. A similar pattern of Mst1/2 substrate phosphorylation is evident in ␣-CD3 ϩ ␣-CD28-stimulated CD4 ϩ /CD62Lhi naïve T cells except little or no stimulation of YAP phosphorylation is evident (Fig.  5A Right) . We also compared wild-type CD4 ϩ /CD62Lhi naïve cells with wild-type CD4 ϩ /CD62Llo effector/memory cells (Fig.  5B) ; as expected from the lower content of Mst1 in the effector/ memory cells (Fig. 3D) , there is a much weaker Mst1/2 autophosphorylation and greatly reduced MOBKL1A/B phosphorylation, despite unaltered MOBKL1A/B polypeptide content.
Given the robust ␣CD3 ϩ ␣CD28-stimulated MOBKL1A/B phosphorylation and its total dependence on Mst1, the relatively modest stimulation of Lats1/2 and YAP phosphorylation and their relative insensitivity to Mst1 elimination is surprising, as is the lack of FoxO1/3a phosphorylation in response to ␣-CD3 ϩ ␣-CD28. We therefore stimulated total splenic T cells with more vigorous, nonspecific stimuli, that is, H 2 O 2 , which is known to activate Mst1/2 (Fig. 5C Left) and PMA ϩ ionomycin (Fig. 5C  Right) , which promotes near maximal T cell activation. Both of these treatment result in activation of Mst1 and vigorous phosphorylation of MOBL1A/B, Lats1/2, YAP, and FoxO1/3a, which are each greatly attenuated or (for MOBKL1A/B) abolished in the Mst1-null T cells. Thus, it is clear that although Lats1/2, YAP and FoxO1/3a are, like MOBKL1A/B, downstream targets of Mst1 in T cells (Fig. 5D) , they are not significantly phosphorylated in wild-type T cells by stimulation with ␣-CD3 ϩ ␣-CD28 that is sufficient to promote a robust proliferative response. Consequently, deficient Mst1-catalyzed Lats1/2 or Foxo1/3 phosphorylation cannot account for the hyperproliferative response of Mst1-null naïve T cells to ␣CD3ϩ␣CD28. Thus, although all three of these potential Mst1 substrates have been shown to exert antiproliferative effects (19, 20, 36) only MOBKL1A/B remains a viable candidate as the effector of Mst1's antiproliferative effect in naïve T cells, as its phosphorylation is stimulated by ␣CD3 ϩ ␣CD28 and lost entirely in the Mst1-null cells. Inasmuch as the best characterized target of phospho-MOBKL1A/B is Lats1 (19, 37) , the present data indicates that other Mst1 substrates and/or targets of phospho-MOBKL1A/B remain to be identified.
Discussion
These data identify a key physiological function of Mst1 in T cells; the Nore1B/Mst1 complex is a major negative regulator of the proliferative response of naïve T cells to stimulation of the T cell antigen receptor. This, together with the marked decrease in Nore1B and Mst1 abundance during the progression of wild-type T cells from a naïve to an effector/memory phenotype strongly supports the conclusion that a physiologic reduction in Nore1B/Mst1 is responsible, at least in part, for the greater sensitivity of effector/memory T cells to antigen receptor activation and the decreased requirement for costimulation to elicit a proliferative response. The two clear-cut cell intrinsic actions of Mst1 itself, that is, its antiproliferative action and its promotion of LFA-1 clustering, would appear to be opposing in their effect on the immune response, however, the impact of the enhanced proliferative responsiveness appears to predominate in the Mst1-null mice, at least in the absence of a specific immune challenge. The Mst1-null mice exhibit relatively normal thymocyte development but many fewer splenic naïve T cells, unaltered lymph node size and increased numbers of effector/memory T cells in several tissues; this phenotype, which differs markedly from that of CD11a (i.e., LFA-1)-deficient mice (38) , is unlikely to be due primarily to aberrant T cell migration, inasmuch as the expression of mRNAs encoding KLF2 (32), S1P 1 and a variety of chemokine receptors is similar in wild-type and Mst1-null CD4 ϩ /CD62Lhi T cells (Fig. S8) . Rather, the low numbers of naïve T cells in the secondary lymphoid organs of the Mst1-null mice is most simply explained by a lower threshold in the Mst1-null naïve T cells for antigen-stimulated proliferation, resulting in their ready activation, presumably in response to endogenous antigens. The increased apoptosis of all Mst1-null T cell subsets may thus reflect the higher ongoing rate of T cell activation and progression through an immune response (31) . This would be expected to be expressed as autoimmunity, however, activation of LFA-1 is required for some immune responses (38) , and ongoing autoimmunity can be interrupted by interference with LFA-1 function (39). Thus, the net outcome of these opposing Mst1 outputs on various aspects of the immune response cannot be confidently predicted and will require more detailed analysis. The coordinate decrease in Nore1B and Mst1 polypeptide abundance emphasizes the operation of Nore1B and Mst1 as a complex in these cells, functioning in a manner analogous to the regulatory and catalytic subunits of, for example, PKA. Nore1 binds in a GTP-dependent way in vitro or in a 2-hybrid assay to several Ras-like GTPases, including Ki-and Ha-Ras, RRas, MRas/RRas3, Rap1, and Rap2a (40); it is likely that more than one of these serves as a physiologic partner depending on the cellular context. Nore1B, the isoform expressed primarily in lymphoid cells, was retrieved in a two-hybrid screen using activated Rap1 (and therefore named RAPL) and endogenous Nore1B can be coprecipitated from T cells with endogenous activated Rap1 (41) . Previous work has shown that a complex of Mst1 and Nore1B mediates the clustering of the integrin LFA-1 in T cells elicited by receptor activation of Rap-1 (6, 7) . Thus, although a specific identification of the ras-like GTPase that underlies the antiproliferative action of the Nore1B/Mst1 complex in naïve T cells remains to be accomplished, Rap1-GTP is the leading candidate.
Materials and Methods
The methods used for the generation and genotyping of Mst1-deficient mice, for the isolation of mouse immune cells, and their characterization by flow cytometry, immunofluorescence, and immunoblotting, as well as methods for Northern blot and for the measurement of T cell Ca ϩϩ flux, proliferation, apoptosis, cytokine production, and adhesion and migration are provided in detail in SI Materials and Methods. Fig. 1 A. The absence of additional insertions was established by the presence of a single band on a Southern blot developed with a probe generated entirely from within the gene trap vector (not shown). The heterozygous ES cells were injected into C57BL/6J blastocyts to produce chimeric mice by using standard methods. Resulting chimaeras were mated with C57Bl6/J mice to produce Mst1 mutant heterozygous mice. Heterozygous mice were backcrossed onto the C57Bl6/J strain for six generations. All comparisons were done using homozygous and wild-type littermate controls. All mice were housed in a temperaturecontrolled room at 22-24°C with a 12-h light/dark cycle and fed a standard laboratory chow diet and double-distilled water. Animal experiments were carried out in accordance with National Institutes of Health (NIH) guidelines for the Care and Use of Experimental Animals and were approved by the institutional Animal Care and Use committee of the Massachusetts General Hospital.
Supporting Information
Mice Genotyping. Genomic DNA extracted from tail (postnatal 3-4 weeks) biopsies was screened for the presence of wild-type and mutant alleles by PCR. One forward primer based on the Mst1 genome sequence (primer a: 5Ј-GGG TCT TGC ACA GTG TCT CA -3Ј) is common for both wild-type and targeted alleles. Two reverse primers based on the Mst1 genome sequence (primer b: 5Ј-TGT CAA GCT CAT GAC TGC A -3Ј) and the targeting vector (primer c: GGGGATGTGCTGCAAGGCGA) were used for PCR to amplify 500-and 250-bp DNA fragments specifically for the wild-type and targeted alleles, respectively. The genotypes were confirmed by Southern blotting. Briefly, Southern blots of BamH I-digested DNA probed with 5Ј probe give rise to a wild-type 10-kb band or a disrupted 8-kb band. 5Ј probe was amplified by the forward primer, GGG AAG GCT TGT GTT GAA T and reverse primer, TAG GGC GCA GTC AAG AAA C.
Northern Blot Analysis. Total RNA was extracted from 5 ϫ 10 6 cells with TRIzol (Invitrogen). Twenty micrograms RNA was separated by electrophoresis in 2% denaturing formaldehydeagarose gels and transferred to a nylon membrane (Hybond Nϩ, Amersham). RNA was cross-linked to the membranes by UV light. After prehybridization, the membrane was hybridized with the cDNA probes for Nore1B, labeled with 32 P by using a random primer DNA labeling kit (Qiagen). The probed membrane was then washed and exposed to radiographic film. Full-length Nore1B cDNA fragments were used as probes for Northern blot assay. The same membrane was reprobed with the Mst1 probe. The Mst1 probe was amplified by PCR using the primers as follows: Mst1 forward, CAC CCG TTT GTT AAG AGT G; reverse, TCA ATG GCA TCC AGG ATT GGC.
Cell Isolation and Stimulation. Single cell suspensions of thymus, spleen, and peripheral lymph nodes of Mst1-null and wild-type littermate control mice were made by disrupting the organs and then filtering them through 70-m filters. Red blood cells were depleted by red cell lysis solution containing 0.15 M NH 4 Cl, 10 mM KHCO 3 , and 0.1 mM Na 2 EDTA. Total T cells were purified by CD90 microbeads, and naïve and memory T cell were isolated using the CD4 ϩ CD62L ϩ T Cell Isolation Kit II (Miltenyi Biotec) according to the manufacturer's protocol. The overall purity of total T cells and the CD4 ϩ /CD62Lhi subset was verified by cytofluorimetry always to be higher than 90 usually 95%. Before TCR stimulation, the cells were rested at 37°C for 2 to 3 h in RPMI 1640 complete medium containing 10% FBS, 25 mM Hepes, 2 mM L-glutamine, 50 M 2-mercaptoethanol (2-ME), 1% non-essential amino acid, and 2 mM sodium pyruvate. For the immunoblot studies shown in Fig. 5 , two million purified T cells were incubated with 10 g/ml anti-CD3 antibody and 10 g/ml anti-CD28 antibody (clone 37.51, BD PharMingen) at 37°C for indicated time points. The cells were quickly spun down and washed with cold PBS once, then frozen on dry ice ready for immunoblot analysis. Following the same procedure, T cells were treated with either 50 ng/ml PMA (Sigma) and 1 M Ionomycin (Sigma) or 0.5 mM H 2 O 2 (Sigma).
Flow Cytometry. Single cell suspensions of spleen or lymph node were resuspended in PBS with 1% BSA and blocked with CD16/CD32 (Fc␥ III/II Receptor) (BD PharMingen. The cells were then stained with the indicated antibodies, washed, and then fixed with paraformaldehyde. The lungs were flushed with cold PBS and excised. Single cell suspensions were obtained by disrupting the tissue with scissors followed by digestion in Blendzyme (Roche) and DNase for 45 min at 37°C and strained through a 70-mm filter. After lysis of red blood cells (RBC lysis buffer, Sigma), the cells were resuspended, counted, and stained for flow cytometry as above.
Antibodies were obtained from BD PharMingen. In some cases, the cells were permeablized and stained with an antibody to murine Foxp3 (eBiosciences) according to the manufacturer's protocol. Flow cytometry was performed on a BD FACScaliber and analyzed with Flowjo software (Treestar).
Ca 2؉ Flux Measurements. Five million lymphocytes isolated from mice 8 weeks of age were loaded with 5 g/ml Fluo4 A.M. (reconstituted in anhydrous DMSO for a working concentration of 1 mg/ml; Molecular Probes/Invitrogen) for 30 min at 37°C with occasional mixing. The cells were washed briefly in complete media (IMDM containing 10% FCSϩFe ϩ2 , 100 M ␤-mercaptoethanol, and 50 g/ml gentamicin) and were then stained with antibodies against CD4 and CD62L (BD Biosciences) for 10 min at room temperature. Cells were then washed and resuspended in complete medium, and then analyzed by flow cytometry (Becton Dickinson FACSCaliber machine and CellQuest Pro software, version 5.2). CD4 ϩ cell populations or CD4ϩCD62LHi cell populations were gated as indicated in Fig.  S11B . Gated, unstimulated cells were collected for 30 s to establish a baseline reading, and were then stimulated with the addition of 2 g of anti-CD3 (BD Biosciences), immediately followed by cross-linking with 5 g of goat anti-Armenian hamster antibodies (Jackson ImmunoResearch). Ca ϩ 2 fluxes were measured for eight minutes, followed by the addition of 0.5 g/ml ionomycin (Sigma) for an additional 30 s. As indicated by the overlay in panel Y, lymphocytes from both wild-type (blue) and Mst1-deficient mice (red) had similar Ca 2ϩ flux and response to the positive control (ionomycin). Data shown is representative of two independent experiments.
Immunoblotting. Cells were lysed in ice-cold lysis buffer containing 1% Triton X-100, 50 mM Tris-HCl (pH 7.4), 10% glycerol, 150 mM NaCl, 2 mM EDTA, 50 mM NaF, 10 mM Na 3 VO 4 , complete Mini protease inhibitor mixture tablet (Roche), and 2 mM PMSF. After centrifugation, cell lysates from 1 ϫ 10 6 were subjected to SDS-polyacrylamide gel electrophoresis and transferred to a PVDF membrane. The blot was incubated with indicated antibodies and visualized by the ECL detection system (Amersham Pharmacia).
The Immunofluorescence Staining. Immunofluorescence staining of splenic sections was performed essentially according to Cariappa et al., (S3) with minor modifications. Spleens were harvested and immediately frozen in OCT compound (Tissue-Tek). Six-m thick sections were cut and stored at -80°C until use. All subsequent manipulations were done at room temperature. Sections were air dried for overnight, fixed in ice-cold acetone for 10 min, air dried briefly, blocked with 5% normal horse serum for 20 min, and incubate with biotin-anti-mouse IgM (R6-60.2, BD PharMingen) at 1:50 dilution for 1 h. After rinsed in PBS (three times, 5 min each), sections were then stained with a 1:500 dilution of streptavidin-Texas red (Jackson Immunoresearch Laboratories) and anti-MOMA-1-FITC (Serotec) for 1 h. Sections were rinsed in PBS (three times, 5 min each). and mounted with mounting medium (Vectashield). Digital images were acquired by using a Nikon Eclipse 800 epifluorescence microscope (Nikon Instruments) equipped with an Orca 100 CCD camera (Hamamatsu). Epifluorescence images were analyzed using IPLab version 3.2.4 image processing software (Scanalytics) and imported into Adobe Photoshop v7.0 (Adobe Systems) for production of the final figures.
T cell staining was performed as previously described (S4). Briefly, purified T cells were fixed with 4% PFA for 15 min at room temperature. Fixed cells were mounted on polyL-lysinecoated slides. Fixed cells were permeabilized for 5 min with 0.2% Triton X-100, and then blocked with 10% goat serum for 20 min. Cells were stained with antibody to LFA-1 a(M17/4, BD PharMingen) at 1:50 dilution for one and half an hour followed by Texas Red-conjugated goat antibody to Rat IgG (Jackson Immunoresearch Laboratories) at 1:500 dilution for 45 min. Unbound antibodies were removed by five washes with PBS plus 0.1% BSA. Stained cells were viewed by Nikon Eclipse 800 epifluorescence microscope.
Annexin V Assay. Annexin V staining was done after initial staining with anti-CD3 (PharMingen) and anti-CD62L with an annexin V staining kit (PharMingen). Cells were subsequently analyzed by flow cytometry on a FACScaliber.
Gene Expression Analysis and Real-time Quantitative PCR. CD4 ϩ cells were immunoisolated and the CD4/CD62Lhi and CD4/CD62Llo subsets were then purified by cell sorting. These cells and the excised mouse tissues were homogenized in TRIzol reagent (Invitrogen). After extraction with chloroform, the RNA was purified using RNeasy mini kit (Qiagen) and reverse transcribed using SuperScript III RT (Invitrogen). Real-time quantitative PCR was performed using Bio-Rad iQ SYBR Green Supermix in the BioRad iCycler iQ system (BioRad). ␤-actin RNA was used to standardize the total amount of cDNA. The sequence of primers was used as follows: Mst1 se:GGA AGC TTC CTC GCA ACT TTG; Mst1 as:GCT CAG GTG ACC TTC CCT GAA; CD25 se:AGA ACA CCA CCG ATT TCT GG; CD25 as:CTG TGG GTT GTG GGA AGT CT; CD4 se:CAC CTG GAA GTT CTC TGA CCA; CD4 as:AAA CGA TCA AAC TGC GAA GG; CD28 se:TGG CTT GCT AGT GAC AGT GG; CD28 as:GCT GGT AAG GCT TTC GAG TG; CD62L se:AAG CTG TGG GTC TGG ACA CT; CD62L as:AGC ATT TTC CCA GTT CAT GG; KLF2 se:AAC TGC GGC AAG ACC TAC AC; KLF2 as:TCC TTC CCA GTT GCA ATG AT; b7-integrin se:GGA CGA CTT GGA ACG TGT G; b7-integrin as:CGT TTT GTC CAC GAA GGA G; S1P1 se:GTG TAG ACC CAG AGT CCT GCG; S1P1 as:AGC TTT TCC TTG GCT GGA GAG; ␤-actin se:AAA TCG TGC GTG ACA TCA AA; ␤-actin as:TCT CCA GGG AGG AAG AGG AT. Other primers are as described in (S5). PCR specificity was examined by analyzing the melting-curves. Relative mRNA levels in Fig. 3D were determined by comparing the PCR cycle threshold between cDNA of CD25, Mst1, or CD4 and that of ␤-actin.
Assay of [ 3 H]-Thymidine Incorporation and Cytokine Production in
Vitro. Two hundred l of purified T cells at a concentration of 1 ϫ 10 6 cells/ml in RPMI 1640 complete medium were added to 96-well plates precoated with 1 g/ml of anti-CD3 with or without 1 g/ml anti-CD28 antibody. Cells were cultured for 24 to 120 h at 37°C and pulsed with 1 Ci of [ 3 H]-thymidine/well for the final 10-12 h of culture. The plates were harvested using a Packard 96-well Filtermate Harvester and counted on a Packard Top Count Scintillation counter. Supernatants from day 1 and day 2 were taken for cytokine ELISA. IL-2, IL-4, and IFN-␥ were done using ELISA Kits (BD Biosciences) according to the manufacturer's directions.
CFSE Labeling. CD3
ϩ T cells (2 ϫ 10 6 cells/ml) were incubated with 5 mM CFSE in PBS containing 5% FBS for 10 min at 37°C. Unbound CFSE was quenched by using an excess of complete medium and incubation on ice for 5 min. Cells were washed three times in complete medium before cell culture. Analyses of CFSE profiles were performed on a FACS Calibur flow cytometer by using CellQuest software by gating on viable CD3 ϩ T cells.
Generation of Th1 and Th2 CD4 ؉ T Cells in Vitro. Naïve CD4 ϩ T cells were isolated from spleen and pooled cervical, axillary and inguinal lymph nodes from Mst1 Ϫ/Ϫ and wild-type mice using a magnetic bead selection kit for CD4 ϩ /CD62L ϩ cells (Miltenyi). Purified CD4 ϩ T cells (1 ϫ 10 6 cells/ml) were activated in the presence of ␣-CD3 (2 mg/ml; 2C11) and ␣-CD28 (1 mg/ml; both from BD PharMingen). Th1 cells were generated by activation of cells in the presence of 100 U/ml IL-12 (PeproTech) and anti-IL-4 (BD PharMingen) at inhibitory concentrations. Th2 cells were generated by activation of cells in the presence of 1,000 U/ml IL-4 (PeproTech) and ␣-IFN-gamma (BD PharMingen) at inhibitory concentrations. Media with 5-10 U/ml IL-2 (PeproTech) was added to the cells on day 2, and the cells were then split every day and used after 6 days in culture. Cytokine expression by intracytoplasmic staining was assayed by cytofluorimetry as in (S6 and S7). CCR2  CCR3  CCR4  CCR5  CCR6  CCR7  CCR8  CCR9  CXCR1  CXCR2  CXCR3  CXCR4  CXCR5  CXCR6  CXCR7  CX3CR1  XCR1  S1P1  KLF2  b7integ  CD28  CD62L  CD4  MST1   CCR8  CCR1  CCR2  CCR3  CCR4  CCR5  CCR6  CCR7  CCR9  KLF2  b7integ  CD28  CD62L  CD4  MST1  S1P1  CX3CR1  CXCR6  CXCR5  CXCR7  CXCR1  CXCR2  CXCR3 Lysates were prepared from antiCD3 ϩ anti-CD28 stimulated splenic Mst1-null and wild-type T cells and immunoblotted with anti-phosphotyrosine specific antibodies specifically directed at PLC ␥, ZAP-70, Lck, and CD3 (top panels) or at whole cell proteins separated on 8% and 12% SDS-polyacrylamide gels (bottom). (B) Calcium responses to CD3 cross-linking in CD4 ϩ /CD62Lhi cells from Mst1-null and wild-type mice. Splenic T cells were loaded with Fura4 washed and labeled with anti-CD4 and anti-CD62L. After gating as indicated, a baseline signal was obtained for 0.5 min with the addition thereafter of anti-CD3 followed immediately by goat anti-Armenian hamster antibodies. After eight minutes, ionomycin was added and further signal was obtained. (C) Akt, MAP kinase, and IB phosphorylation in Mst1-null and wild-type T cells. Splenic CD3 ϩ (left) and CD4 ϩ /CD62Lhi (right) cells were isolated from Mst1-null and wild-type littermates. After resting in vitro, the cells were stimulated with anti-CD3 ϩ anti-CD28; extracts prepared at the times indicated were subjected to immunoblot with the antibodies designated. Actin served as loading control. The middle lane contains M r markers.
